๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Early deaths in acute lymphoblastic leukemia (ALL): Results of the Italian pediatric cooperative group for therapy of acute leukemia (AIL-AIEOP)

โœ Scribed by Dini, Giorgio ;Bartolini, Marida ;Massimo, Luisa ;Ceci, Adriana ;Paolucci, Guido ;Calculli, Giovanni ;Russo, Antonio ;Magro, Saverio ;Guazzelli, Carlo ;Cesana, Bruno M. ;Jankovic, Moncilio ;Massolo, Fausta ;Di Tullio, Maria T. ;Curto, Margherita Lo ;Marchi, Antonietta ;Macchia, Pier Antonio ;Mandelli, Franco ;Digilio, Girolamo ;Rosati, Domenico ;Acquaviva, Antonio ;Madon, Enrico ;Miniero, Roberto ;Tamaro, Paolo


Publisher
John Wiley and Sons
Year
1984
Tongue
English
Weight
379 KB
Volume
12
Category
Article
ISSN
0098-1532

No coin nor oath required. For personal study only.

โœฆ Synopsis


In this retrospective multicentric study, we report on early deaths (ie, those that occurred during the first month of treatment) in a total of 943 newly diagnosed ALL pediatric patients registered from 1976 to 1981 at 21 centers of the AlL-AIEOP. Objectives of this study were as follows: (1) to verify the incidence and the cause of early death in a wide population of children with ALL and (2) to elucidate factors associated with early death and therefore to identify "high-risk" groups of patients.

Out of the 943 ALL patients, 39 (4.1%) early deaths were registered. Main causes were infection, 20 patients (51.3%); hemorrhage, 11 patients (28.3%); uric acid nephropathy, 2 patients (5.1%); cardiac failure, 3 patients (7.6%); syndrome of inappropriate antidiuretic hormone secretion, 1 patient. Two patients died during the first week of unknown cause. Thirteen factors measured at diagnosis and possibly influencing the early death rate were analyzed. Using the chi-square test, only three of these factors (age, mediastinum status, surface markers) appear to have any significant influence on the early death rate. We also tried to determine how therapy influences this process by analyzing variations in the early death rate, other factors being equal. Significant differences in the early death rates were encountered in AIEOP protocols using different induction regimens.


๐Ÿ“œ SIMILAR VOLUMES


Acute and chronic hepatitis in childhood
โœ Locasciulli, A. ;Alberti, A. ;Rossetti, F. ;Santamaria, M. ;Santoro, N. ;Madon, ๐Ÿ“‚ Article ๐Ÿ“… 1985 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 387 KB

The incidence of acute and chronic liver damage and its relation to hepatitis B virus (HBV) infection was evaluated in 164 consecutive children with acute leukemia seen in ten Italian hemato-pediatric units. Thirteen out of 164 children (7.9%) had acute hepatitis (AH) during treatment, while 8/90 (8

Impact of the timing of triple intrathec
โœ Hvizdala, Eva ;Berry, D. H. ;Chen, Timothy ;Dyment, Paul G. ;Kim, Tae H. ;Steube ๐Ÿ“‚ Article ๐Ÿ“… 1984 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 446 KB

Five weekly doses of triple intrathecal (IT) chemotherapy (methotrexate, hydrocortisone, cytosine arabinoside) starting on day 1 of treatment were added to systemic induction therapy in a regimen (Arm 3) that was compared to three other regimens (Arms 1, 2, and 4) in which central nervous system (CN

Clinical significance of Philadelphia ch
โœ Fatih M. Uckun; James B. Nachman; Harland N. Sather; Martha G. Sensel; Peter Kra ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 136 KB ๐Ÿ‘ 3 views

## BACKGROUND. Children with Philadelphia (Ph) chromosome positive ( ฯฉ ) acute lymphoblastic leukemia (ALL) represent a subgroup at very high risk for treatment failure. In this report, the authors assessed the outcome of Ph ฯฉ ALL in a large cohort of children treated on contemporary intensive che